Knauss v. Ultimate Nutrition, Inc.

514 F. Supp. 2d 241, 2007 U.S. Dist. LEXIS 68805, 2007 WL 2727473
CourtDistrict Court, D. Connecticut
DecidedSeptember 18, 2007
Docket3:06cv842 (JBA)
StatusPublished
Cited by1 cases

This text of 514 F. Supp. 2d 241 (Knauss v. Ultimate Nutrition, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Knauss v. Ultimate Nutrition, Inc., 514 F. Supp. 2d 241, 2007 U.S. Dist. LEXIS 68805, 2007 WL 2727473 (D. Conn. 2007).

Opinion

RULING ON THIRD-PARTY DEFENDANT’S MOTION TO DISMISS FOR LACK OF JURISDICTION AND IMPROPER VENUE [DOC. #31]

JANET BOND ARTERTON, District Judge.

In this diversity action, plaintiff Hans Knauss, a former Olympic silver medalist alpine skier and “superstar in Austria and around the world,” was bound for the Olympic Games in Torino, Italy when he was suspended from competition after testing positive for banned substances. His complaint claims that these test results were caused by his unwitting consumption of nutritional supplements containing norandrostenedione,' a steroid. (Am. Compl. [Doc. #44] ¶¶ 9, 12, 13, 23.) As a consequence, Mr. Knauss was unable to compete at the Olympics, allegedly resulting in his humiliating losses of endorsements, sponsorships, and income, and a permanently tarnished reputation. (Id. at ¶¶ 18, 26.) Mr. Knauss has brought this action against defendant/third-party plaintiff Ultimate Nutrition, Inc. (“UNI”), the manufacturer of the “Super Complete” nutritional supplement he consumed, for damages resulting from his eighteen-month suspension from skiing competition. (Id.)

UNI in turn has sued AMT Labs, Inc. (“AMT”) as a third-party defendant. UNI alleges that AMT’s premix, which was supplied to and used by UNI to make the Super Complete capsules, contained the norandrostenedione. (Third Party Compl. [Doc. # 13] ¶ 4.) UNI asserts that any liability on its part would be the result of AMT’s negligence, improper manufacture, improper labeling, carelessness, culpable conduct, and/or breach of contract. (Id. ¶¶ 21-26.) UNI further claims that if it is held liable for the damages alleged in the Complaint then it is entitled to indemnification from AMT pursuant to Conn. Gen. Stat. § 52-577a. (Id. ¶¶ 20-26.)

AMT has moved to dismiss this action for lack of personal jurisdiction pursuant and for improper venue pursuant to Fed. R.Civ.P. 12(b)(2) and (b)(3). (Third-Party Def.’s Mot. to Dismiss [Doc. # 31].) For *244 the reasons set forth below, AMT’s Motion to Dismiss is denied.

I. FACTUAL BACKGROUND

Around June 24, 2003, UNI purchased from AMT a quantity of Super Complete premix, termed “UL Super Complete Capsules, Granular, Premix,” with lot number J051306C. (Third-Party Compl. ¶ 8.) This was the third time UNI had purchased materials from AMT. (Fang Aff. [Doc. # 32-2] ¶ 11.) AMT provided a certifícate of analysis to UNI with this product which did not list 19-norandrosterone or noran-drostenedione as a content. (Third-Party Compl. ¶ 9.) Approximately 66.7 percent 6f UNI’s Super Complete capsules were composed of AMT’s premix. (Id. ¶4.) This identified lot of AMT’s premix was used by UNI to produce lot number 404001 of UNI’s Super Complete capsules. (Id. ¶11.)

In November 2004, Mr. Knauss purchased a container of Super Complete capsules from lot number 404001 and followed the directions on the label for consumption. (Am.Compl^ 10.) Prior to purchasing or taking Super Complete, Mr. Knauss alleges he read literature on UNI and its products and confirmed with UNI 1 that its product was appropriate for his needs and was safe and free from any substance that would disqualify him from competition under the anti-doping regulations of the International Ski Federation (“FIS”), the World Anti-Doping Agency (“WADA”), and the International Olympic Committee (“IOC”). (Id. ¶ 11.)

Mr. Knauss was subject to regular drug testing by FIS, WADA and the IOC. (Id. ¶ 14.) On November 27, 2004, he provided a required urine sample to compete in the FIS Apiñe World Cup Downhill Competition in Lake Louise, Canada. When analyzed 2 his sample was found contaminated with the prohibited substance 19-noran-drosterone, a known metabolite of noran-drostenedione. 3 As a result of testing positive for a banned substance, Mr. Knauss was suspended from skiing competition for eighteen months. (Id. ¶¶ 18-22.)

In December 2004, Mr. Knauss claims he sent the container of Super Complete from lot number 404001 to Seibersdorf Research (“Seibersdorf’) in Seibersdorf, Austria for analysis, which reported that it contained norandrostenedione despite the fact that the label failed to disclose that substance or any steroid or steroid precursors as ingredients. (Id. ¶¶ 23-24.) AMT allegedly admitted that it also has suppliers that produce certain steroids in AMT’s facilities. (Id. ¶ 12.)

Mr. Knauss alleges that his losses and damages were a result of the negligence of UNI. UNI claims, in turn, that any damages sustained by Mr. Knauss because of the alleged presence of norandrostene-dione in the Super Complete capsules were *245 caused by the contamination of AMT’s premix used in those capsules.

II. DISCUSSION

A. Personal Jurisdiction

When responding to a motion to dismiss for lack of personal jurisdiction pursuant to Fed.R.Civ.P. 12(b)(2), third-party plaintiff UNI bears “the burden of establishing that the court has jurisdiction over the defendant.” Bank Brussels Lambert v. Fiddler Gonzalez & Rodriguez, 171 F.3d 779, 784 (2d Cir.1999). In ruling on a motion to dismiss, the procedural path the district court follows determines the plaintiffs burden of proof. CutCo Indus., Inc. v. Naughton, 806 F.2d 361, 364 (2d Cir.1986). The parties in this case have been allowed limited discovery regarding the issue of jurisdiction, but the Court declined to hold a full evidentiary hearing. In these circumstances, “the plaintiffs prima facie showing, necessary to defeat a jurisdiction testing motion, must include an averment of facts that, if credited by the trier, would suffice to establish jurisdiction over the defendant.” Ball v. Metallurgie Hoboken-Overpelt, S.A., 902 F.2d 194, 197 (2d Cir.1990); see also Metro. Life Ins. Co. v. Robertson-Ceco Corp., 84 F.3d 560, 566-67 (2d Cir.1996). In determining the propriety of exercising personal jurisdiction over a nonresident defendant, courts first look to whether jurisdiction is permitted under the relevant state long-arm statute, and, if so, then to whether such jurisdiction is also consistent with the Due Process Clause of the 14th Amendment. Savin v. Ranier, 898 F.2d 304

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Wis. Province Jesus v. Cassem
373 F. Supp. 3d 378 (D. Connecticut, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
514 F. Supp. 2d 241, 2007 U.S. Dist. LEXIS 68805, 2007 WL 2727473, Counsel Stack Legal Research, https://law.counselstack.com/opinion/knauss-v-ultimate-nutrition-inc-ctd-2007.